Baseline testing of fasting glucose, HbA1c, and lipid panels before starting combined therapy helps establish whether additional monitoring intervals are needed during treatment
Three landmark trials (Action to Control Cardiovascular Risk in Diabetes [ACCORD], Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation [ADVANCE], and Veterans Affairs Diabetes Trial [VADT]) were conducted to test the effects of near normalization of blood glucose on cardiovascular outcomes in individuals with long-standing type 2 diabetes and either known cardiovascular disease (CVD) or high cardiovascular risk
New England Journal of Medicine, 388(2), 117-127
For both the patient and the pharma company, this failure is significant, but for very different reasons
Clinical evidence and research cited herein shows that the ingredients in Acetyl-L-Carnitine may: Promotes healthy brain function Supports energy metabolism Supports healthy immune function Supports healthy response to oxidative stress Promotes balanced moods Promotes exercise capacity